This inventor holds 1 USPTO granted patent. Top assignee: Suven Life Sciences Limited. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Shreekrishna Shirsath Vikas: Innovator in Pharmaceutical Chemistry
Introduction
Shreekrishna Shirsath Vikas is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address various health disorders. His work is characterized by a commitment to innovation and the advancement of medical science.
Latest Patents
Shreekrishna holds 1 patent for his invention titled "Indeno[2,1A]indenes and isoindolo[2,1-A]indoles." This invention provides derivatives of indeno[2,1a]indene and isoindolo[2,1-a]indole, including their salts and stereoisomers. The compounds are designed to be useful in treating a range of conditions, including CNS disorders, hematological disorders, eating disorders, diseases associated with pain, respiratory diseases, genito-urological disorders, cardiovascular diseases, and cancer. The invention also outlines a method for preparing these compounds and their pharmaceutical compositions.
Career Highlights
Shreekrishna is currently associated with Suven Life Sciences Limited, where he continues to contribute to innovative research and development in the pharmaceutical sector. His work at the company reflects a dedication to improving health outcomes through scientific advancements.
Collaborations
Shreekrishna has collaborated with notable colleagues, including Satya Nirogi Ramakrishna Venkata and Sastri Kambhampati Rama. These collaborations have further enriched his research and development efforts.
Conclusion
Shreekrishna Shirsath Vikas exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions through patents and collaborations highlight the importance of research in addressing critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile